Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.815 USD | -2.93% | 0.00% | -67.69% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.69% | 303M | |
+0.82% | 93.19B | |
0.00% | 39.62B | |
-11.88% | 33.78B | |
+65.27% | 26.82B | |
-16.29% | 15.35B | |
-6.43% | 13.13B | |
-11.77% | 11.6B | |
-49.19% | 10.26B | |
+4.19% | 9.43B |
- Stock Market
- Equities
- RVNC Stock
- News Revance Therapeutics, Inc.
- Barclays Adjusts Price Target on Revance Therapeutics to $40 From $37, Maintains Overweight Rating